Silo Pharma Announces Private Placement of Equity Definitive Agreement for $4.275 Million in Gross Proceeds Post published:February 10, 2021 Post category:Press Release
Field Trip Health Ltd. Schedules Third Fiscal Quarter 2021 Financial Results Conference Call for Wednesday, February 17, 2021 at 8:00 am ET Post published:February 10, 2021 Post category:Press Release
Psyence Group Signs Collaboration Agreement with Leading Jamaican Psilocybin Retreat Provider to Conduct Observational Study Post published:February 10, 2021 Post category:Press Release
NeonMind Submits Applications to Health Canada for Product Formulas to Support Cognitive and Immune Function and to Fight Stress Post published:February 10, 2021 Post category:Press Release
Nova Mentis Psilocybin Approved for Shipment to Italy Post published:February 9, 2021 Post category:Press Release
COMPASS Pathways expands its Discovery Center through new collaborations with world-leading scientists Post published:February 9, 2021 Post category:Press Release
Field Trip Health Ltd. Announces Official Opening of Psychedelic Research and Cultivation Facility in Jamaica Post published:February 9, 2021 Post category:Press Release
Tryp Therapeutics Plans Phase 2a Eating Disorder Clinical Trial with Dr. Jennifer Miller Post published:February 8, 2021 Post category:Press Release
Algernon Pharmaceuticals Signs Agreement with Charles River Laboratories for DMT Preclinical Studies Post published:February 8, 2021 Post category:Press Release
Numinus Wellness Completes Acquisition of Montreal-based Mindspace Wellbeing Post published:February 8, 2021 Post category:Press Release